Drugs@FDA: FDA-approved drugs
U.S. Food and Drug Administration · U.S. Food and Drug Administration
Open original sourceResearch index · 23 reviewed sources
Start with the source.
Browse the public regulator records, trial registrations, and peer-reviewed human studies currently used by Aliquot. Every source links back to the relevant library records.
Showing all 23 sources.
TRIUMPH-3 retatrutide phase 3 study
ClinicalTrials.gov · U.S. National Library of Medicine
Open original sourceCagrilintide phase 3 weight-management study
ClinicalTrials.gov · U.S. National Library of Medicine
Open original sourceSurvodutide phase 3 study in adults without type 2 diabetes
ClinicalTrials.gov · U.S. National Library of Medicine
Open original sourceTrulicity (dulaglutide) prescribing information
U.S. Food and Drug Administration · U.S. Food and Drug Administration
Open original sourceImcivree (setmelanotide) prescribing information
U.S. Food and Drug Administration · U.S. Food and Drug Administration
Open original sourceWegovy (semaglutide) prescribing information
U.S. Food and Drug Administration · U.S. Food and Drug Administration
Open original sourceVictoza (liraglutide) prescribing information
U.S. Food and Drug Administration · U.S. Food and Drug Administration
Open original sourceFDA grants accelerated approval to first treatment for Barth syndrome
U.S. Food and Drug Administration · U.S. Food and Drug Administration
Open original sourceForzinity (elamipretide) prescribing information
U.S. Food and Drug Administration · U.S. Food and Drug Administration
Open original sourceZepbound (tirzepatide) prescribing information
U.S. Food and Drug Administration · U.S. Food and Drug Administration
Open original sourceByetta (exenatide) prescribing information
U.S. Food and Drug Administration · U.S. Food and Drug Administration
Open original sourceEgrifta SV (tesamorelin) prescribing information
U.S. Food and Drug Administration · U.S. Food and Drug Administration
Open original sourceTriple-hormone-receptor agonist retatrutide for obesity
The New England Journal of Medicine · Jastreboff AM, et al.
Open original sourceSafety, tolerability, pharmacokinetics, and pharmacodynamics of cagrilintide with semaglutide
The Lancet · Enebo LB, et al.
Open original sourceVyleesi (bremelanotide) prescribing information
U.S. Food and Drug Administration · U.S. Food and Drug Administration
Open original sourceSymlin (pramlintide acetate) prescribing information
U.S. Food and Drug Administration · U.S. Food and Drug Administration
Open original sourcePharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine male healthy volunteers
European Journal of Pharmaceutical Sciences · Cabrales A, et al.
Open original sourceGeref (sermorelin acetate) historical prescribing information
U.S. Food and Drug Administration · U.S. Food and Drug Administration
Open original sourceProlonged stimulation of growth hormone and IGF-I secretion by CJC-1295 in healthy adults
The Journal of Clinical Endocrinology & Metabolism · Teichman SL, et al.
Open original sourcePharmacokinetic-pharmacodynamic modeling of ipamorelin in human volunteers
Pharmaceutical Research · Gobburu JV, et al.
Open original sourcePharmacokinetics of thymosin alpha 1 in healthy volunteers
International Journal of Clinical Pharmacology and Therapeutics · Rost KL, et al.
Open original sourceGrowth hormone-releasing activity of hexarelin after intravenous, subcutaneous, intranasal, and oral administration in man
The Journal of Clinical Endocrinology & Metabolism · Ghigo E, et al.
Open original sourceNo reviewed sources match that search.